Yes, Keynote 200 (Cavatak/Keytruda) includes a study with non small cell lung cancer. Lots of other companies are running Phase 3 trials with a chemo/PD1 combos. We need to get in there too!
Yes, Keynote 200 (Cavatak/Keytruda) includes a study with non...
Add to My Watchlist
What is My Watchlist?